• search hit 17 of 45
Back to Result List

Disclosing tumor biology by means of molecular imaging in a patient with malignant melanoma and chronic lymphocytic leukemia

  • Figure C-X-C motif chemokine receptor 4 (CXCR4) plays a major role in tumor growth and the process of metastasis and is thus a highly attractive target in oncology [1]. Non-invasive chemokine receptor imaging using positron emission tomography (PET) has demonstrated promising results, especially in hematologic malignancies including multiple myeloma or lymphoma [2]. Tumor detection in solid cancers is more heterogeneous (as compared to [18F]-fluorodeoxyglucose ([18F]FDG)) with many entities showing only low to moderate in vivo CXCR4 expression [3, 4]. A 73-year-old male with a history of Binet Stage B chronic lymphatic leukemia (CLL), and lentigo maligna melanoma (UICC IA) presented for re-staging with a rapidly enlarging cervical mass as well as new liver lesions (detected by previous ultrasound). [18F]FDG-PET/computed tomography (CT) displayed high uptake in the cervical mass and liver lesions. In addition, pulmonary and osteolytic bone lesions with intense [18F]FDGFigure C-X-C motif chemokine receptor 4 (CXCR4) plays a major role in tumor growth and the process of metastasis and is thus a highly attractive target in oncology [1]. Non-invasive chemokine receptor imaging using positron emission tomography (PET) has demonstrated promising results, especially in hematologic malignancies including multiple myeloma or lymphoma [2]. Tumor detection in solid cancers is more heterogeneous (as compared to [18F]-fluorodeoxyglucose ([18F]FDG)) with many entities showing only low to moderate in vivo CXCR4 expression [3, 4]. A 73-year-old male with a history of Binet Stage B chronic lymphatic leukemia (CLL), and lentigo maligna melanoma (UICC IA) presented for re-staging with a rapidly enlarging cervical mass as well as new liver lesions (detected by previous ultrasound). [18F]FDG-PET/computed tomography (CT) displayed high uptake in the cervical mass and liver lesions. In addition, pulmonary and osteolytic bone lesions with intense [18F]FDG accumulation could be detected (A). In contrast, CT showed various additional enlarged lymph nodes and splenomegaly with only minimal [18F]FDG uptake (A). Thus, CXCR-directed imaging was added. Contrary to [18F]FDG, [68Ga]Ga-PentixaFor displayed intense tracer uptake -consistent with CLL- in the enlarged lymph nodes, bone marrow and spleen, and minimal uptake in the aforementioned [18F]FDG-avid sites, suggestive of melanoma metastases (B). Immunohistochemical staining confirmed these findings showing high GLUT1 (C) and low CXCR4 expression (D) in an osteolytic melanoma lesion (arrows; SUVmax 14.0 vs. 2.2) as opposed to intense CXCR4 expression (E) in a site with osseous CLL infiltration (dotted arrows; SUVmax 2.6 vs. 9.1). Our case highlights the ability of molecular imaging to non-invasively phenotype disease and visualize tumor biology.show moreshow less

Download full text files

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Alexander Gäble, Johanna S. Enke, Martin J. Hügle, Przemyslaw Grochowski, Martin TrepelGND, Alexander DierksORCiDGND, Christian H. Pfob, Ralph A. Bundschuh, Constantin LapaORCiDGND, Malte Kircher
URN:urn:nbn:de:bvb:384-opus4-1145666
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/114566
ISSN:1619-7070OPAC
ISSN:1619-7089OPAC
Parent Title (English):European Journal of Nuclear Medicine and Molecular Imaging
Publisher:Springer Science and Business Media LLC
Type:Article
Language:English
Year of first Publication:2024
Publishing Institution:Universität Augsburg
Release Date:2024/08/01
Volume:52
Issue:1
First Page:366
Last Page:367
DOI:https://doi.org/10.1007/s00259-024-06834-3
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Allgemeine und Spezielle Pathologie
Medizinische Fakultät / Lehrstuhl für Innere Medizin mit Schwerpunkt Hämatologie und Onkologie
Medizinische Fakultät / Lehrstuhl für Nuklearmedizin
Nachhaltigkeitsziele
Nachhaltigkeitsziele / Ziel 3 - Gesundheit und Wohlergehen
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Licence (German):CC-BY 4.0: Creative Commons: Namensnennung (mit Print on Demand)